CNS Pharmaceuticals, Inc. (CNSP) Current Reports & Earnings Releases
| Filed | Form | Items | Filing |
|---|---|---|---|
| 2026-07-02 | 8-K | Reg FD Disclosure, Financial Statements & Exhibits | SEC |
| 2026-05-04 | 8-K | Material Agreement, Unregistered Sales, Officer / Director Changes, Financial Statements & Exhibits | SEC |
| 2026-03-11 | 8-K | Reg FD Disclosure, Financial Statements & Exhibits | SEC |
| 2026-03-02 | 8-K | Officer / Director Changes, Financial Statements & Exhibits | SEC |
| 2026-02-17 | 8-K | Officer / Director Changes, Financial Statements & Exhibits | SEC |
| 2025-12-17 | 8-K | Officer / Director Changes, Financial Statements & Exhibits | SEC |
| 2025-11-21 | 8-K | Officer / Director Changes, Charter Amendments, Shareholder Vote Results, Financial Statements & Exhibits | SEC |
| 2025-07-22 | 8-K | Item 3.03, Charter Amendments, Other Events, Financial Statements & Exhibits | SEC |
| 2025-07-15 | 8-K | Reg FD Disclosure, Financial Statements & Exhibits | SEC |
| 2025-05-15 | 8-K | Material Agreement, Financial Statements & Exhibits | SEC |
| 2025-04-09 | 8-K | Reg FD Disclosure, Financial Statements & Exhibits | SEC |
| 2025-03-31 | 8-K | Other Events | SEC |
| 2025-03-20 | 8-K | Other Events, Financial Statements & Exhibits | SEC |
| 2025-02-21 | 8-K | Item 3.03, Other Events, Financial Statements & Exhibits | SEC |
| 2025-01-03 | 8-K | Reg FD Disclosure, Other Events, Financial Statements & Exhibits | SEC |
| 2024-12-11 | 8-K | Reg FD Disclosure, Financial Statements & Exhibits | SEC |
| 2024-12-03 | 8-K | Shareholder Vote Results | SEC |
| 2024-11-01 | 8-K | Other Events | SEC |
| 2024-10-24 | 8-K | Material Agreement, Other Events, Financial Statements & Exhibits | SEC |
| 2024-10-23 | 8-K | Other Events | SEC |
| 2024-09-18 | 8-K | Listing Notice | SEC |
| 2024-09-12 | 8-K | Listing Notice | SEC |
| 2024-08-07 | 8-K | Other Events | SEC |
| 2024-07-30 | 8-K | Material Agreement, Unregistered Sales, Reg FD Disclosure, Financial Statements & Exhibits | SEC |
| 2024-07-30 | 8-K | Other Events, Financial Statements & Exhibits | SEC |
| 2024-07-26 | 8-K | Material Agreement, Financial Statements & Exhibits | SEC |
| 2024-07-24 | 8-K | Listing Notice | SEC |
| 2024-07-09 | 8-K | Other Events | SEC |
| 2024-07-03 | 8-K | Material Agreement, Unregistered Sales, Other Events, Financial Statements & Exhibits | SEC |
| 2024-06-26 | 8-K | Material Agreement, Unregistered Sales, Other Events, Financial Statements & Exhibits | SEC |
| 2024-06-14 | 8-K | Material Agreement, Unregistered Sales, Other Events, Financial Statements & Exhibits | SEC |
| 2024-06-05 | 8-K | Item 3.03, Charter Amendments, Other Events, Financial Statements & Exhibits | SEC |
| 2024-05-16 | 8-K | Results of Operations, Financial Statements & Exhibits | SEC |
| 2024-05-07 | 8-K | Other Events | SEC |
| 2024-05-03 | 8-K | Officer / Director Changes, Charter Amendments, Shareholder Vote Results, Financial Statements & Exhibits | SEC |
| 2024-04-15 | 8-K | Reg FD Disclosure, Financial Statements & Exhibits | SEC |
| 2024-04-01 | 8-K | Results of Operations, Financial Statements & Exhibits | SEC |
| 2024-02-27 | 8-K | Listing Notice, Officer / Director Changes | SEC |
| 2024-02-21 | 8-K | Listing Notice | SEC |
| 2024-02-02 | 8-K | Material Agreement, Officer / Director Changes, Financial Statements & Exhibits | SEC |
| 2024-01-23 | 8-K | Officer / Director Changes | SEC |
Sourced from SEC EDGAR 8-K/6-K filings. 8-K is the current-report form for US domestic issuers (Item 2.02 = earnings release); 6-K is the equivalent for foreign private issuers, including ADRs. Originals live on sec.gov.